Showing results (731-740 of 748) with videos related to
Sort By:
Pageof 75
Advances in Radiation Oncology|June 15, 2026
Robustness of Tumor Control Against Intrafraction Patient Motion in Lung Stereotactic Body Radiation TherapyYohan A Walter, Chiachien J Wang, Daniel B Speir, et al.Scientific Reports|December 1, 2025
Mitochondrial glutathione transporter SLC25A40 regulates macrophage cytokine productionMaureen Yin, Eva M Palsson-McDermott, Órlaith C Henry, et al.Science Advances|January 22, 2025
Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasionAlessia Zotta, Juliana Toller-Kawahisa, Eva M Palsson-McDermott, et al.Journal of Affective Disorders|August 4, 2020
Evolution and characteristics of the use of valproate in women of childbearing age with bipolar disorder: Results from the FACE-BD cohortL Samalin, O Godin, E Olié, et al.The American Journal of Surgical Pathology|August 19, 2008
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimensAndrew J Evans, Pauline C Henry, Theodorus H Van der Kwast, et al.Veterinary and Comparative Oncology|January 13, 2012
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumoursC London, T Mathie, N Stingle, et al.Cell Reports|January 26, 2022
Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasionElizabeth R Murray, Shinelle Menezes, Jack C Henry, et al.Molecular Psychiatry|March 15, 2006
Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14B Etain, F Mathieu, M Rietschel, et al.Nutrients|August 28, 2020
Dietary Fibre Consensus from the International Carbohydrate Quality Consortium (ICQC)Livia S A Augustin, Anne-Marie Aas, Arnie Astrup, et al.Lancet (London, England)|December 8, 2009
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years, B Romanowski, P Colares de Borba, et al.Pageof 75